Inozyme Pharma Inc

NASDAQ:INZY   3:59:56 PM EDT
6.80
-0.12 (-1.73%)
Earnings Announcements

Inozyme Pharma Reports Third Quarter 2021 Financial Results And Provides Business Highlights

Published: 11/09/2021 22:25 GMT
Inozyme Pharma Inc (INZY) - Inozyme Pharma Reports Third Quarter 2021 Financial Results and Provides Business Highlights.
Inozyme Pharma Inc- Qtrly Loss per Share $0.60.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.67

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.62

More details on our Analysts Page.